Physician profile
Christopher Cooper
NPI 1366925919
$1,019.47
in general payments reported to CMS, 2019-2025
10 companies · $60.30 in 2025
The $60.30 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $394 · 2022: $122 · 2023: $177 · 2024: $266 · 2025: $60.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $266.78 | 2021 | |
| Ethicon US, LLC | $222.42 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $142.00 | 2023-2024 | Fasenra, Imfinzi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.75 | 2024 | |
| Merck Sharp & Dohme LLC | $84.31 | 2023-2025 | Keytruda |
| Stryker Corporation | $52.34 | 2023 | 1788 |
| Becton, Dickinson and Company | $51.83 | 2024 | Progel Applicator Spray Tips |
| Janssen Biotech, INC. | $44.03 | 2025 | Rybrevant |
| Atricure, INC. | $34.83 | 2024 | |
| Medtronic, INC. | $27.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.